Unresectable Locally Advanced Pancreatic Cancer: Treatment With Neoadjuvant Leucovorin, Fluorouracil, Irinotecan, and Oxaliplatin and Assessment of Surgical Resectability

被引：9
|
作者：
Mondo, Esther Liu [1 ]
Noel, Marcus S. [2 ]
Katz, Alan W. [2 ]
Schoeniger, Luke O. [2 ]
Hezel, Aram F. [2 ]
机构：
[1] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14627 USA
[2] Univ Rochester, Med Ctr, Sch Med & Dent, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 03期
关键词：
CHEMOTHERAPY; GEMCITABINE;
D O I：
10.1200/JCO.2012.44.0339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E37 / E39
页数：3
相关论文
共 50 条
  • [1] A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer
    Cecchini, Michael
    Miccio, Joseph A.
    Pahade, Jay
    Lacy, Jill
    Salem, Ronald R.
    Johnson, Skyler B.
    Blakaj, Adriana
    Stein, Stacey
    Kortmansky, Jeremy S.
    Johung, Kimberly L.
    PANCREAS, 2020, 49 (07) : 904 - 911
  • [2] Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
    Kornek G.V.
    Schratter-Sehn A.
    Marczell A.
    Depisch D.
    Karner J.
    Krauss G.
    Haider K.
    Kwasny W.
    Locker G.
    Scheithauer W.
    British Journal of Cancer, 2000, 82 (1) : 98 - 103
  • [3] Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
    Kornek, GV
    Schratter-Sehn, A
    Marczell, A
    Depisch, D
    Karner, J
    Krauss, G
    Haider, K
    Kwasny, W
    Locker, G
    Scheithauer, W
    BRITISH JOURNAL OF CANCER, 2000, 82 (01) : 98 - 103
  • [4] Restaging and assessment of resectability of locally advanced pancreatic cancer by EUS after neoadjuvant therapy
    Walker, Jon
    Chaudhary, Uzair
    Nestor, Esnaola E.
    Romagnuolo, Joseph
    Hawes, Robert H.
    Hoffman, Brenda
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB212 - AB213
  • [5] Restaging and assessment of resectability of locally advanced pancreatic cancer by EUS after neoadjuvant therapy
    Walker, Jon
    Chaudhary, Uzair
    Esnaola, Nestor
    Romagnuolo, Joseph
    Hawes, Robert
    Hoffman, Brenda
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (02) : S266 - S266
  • [6] NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer
    Sahora, Klaus
    Kuehrer, Irene
    Eisenhut, Axel
    Akan, Belgin
    Koellblinger, Claus
    Goetzinger, Peter
    Teleky, Bela
    Jakesz, Raimund
    Peck-Radosavljevic, Markus
    Ba'ssalamah, Ahmed
    Zielinski, Christoph
    Gnant, Michael
    SURGERY, 2011, 149 (03) : 311 - 320
  • [7] Oxaliplatin, 5-Fluorouracil, and Leucovorin as Second-Line Treatment for Advanced Pancreatic Cancer
    Novarino, Anna
    Satolli, Maria Antonietta
    Chiappino, Isabella
    Giacobino, Alice
    Bellone, Graziella
    Rahimi, Farnaz
    Milanesi, Enrica
    Bertetto, Oscar
    Ciuffreda, Libero
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 44 - 48
  • [8] Irinotecan/Fluorouracil/Leucovorin or the Same Regimen Followed by Oxaliplatin/Fluorouracil/Leucovorin in Metastatic Colorectal Cancer
    Kalofonos, Haralabos P.
    Papakostas, Pavlos
    Makatsoris, Thomas
    Papamichael, Demetrios
    Vourli, Georgia
    Xanthakis, Ioannis
    Aravantinos, Gerasimos
    Papadimitriou, Christos
    Pentheroudakis, George
    Varthalitis, Ioannis
    Samelis, George
    Syrigos, Kostas N.
    Xiros, Nikolaos
    Stavropoulos, Michalis
    Kosmidis, Paris
    Christodoulou, Christos
    Linardou, Helen
    Skondra, Maria
    Pectasides, Dimitrios
    Economopoulos, Theofanis
    Fountzilas, George
    ANTICANCER RESEARCH, 2010, 30 (10) : 4325 - 4333
  • [9] Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
    Grothey, A
    Sargent, D
    Goldberg, RM
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1209 - 1214
  • [10] 5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer
    Grande, C.
    Martinez, M.
    Villanueva, M. J.
    Huidobro, G.
    Casal, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S469 - S469
12345